Cargando…

Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma

BACKGROUND: Fatigue is a common adverse event during lenvatinib treatment in patients with hepatocellular carcinoma. One mechanism contributing to development of fatigue might involve abnormal adenosine triphosphate synthesis that is caused by carnitine deficiency. To address this possibility, we ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okubo, Hironao, Ando, Hitoshi, Ishizuka, Kei, Kitagawa, Ryuta, Okubo, Shoki, Saito, Hiroaki, Kokubu, Shigehiro, Miyazaki, Akihisa, Ikejima, Kenichi, Shiina, Shuichiro, Nagahara, Akihito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053710/ https://www.ncbi.nlm.nih.gov/pubmed/32126131 http://dx.doi.org/10.1371/journal.pone.0229772

Ejemplares similares

Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis
por: Okubo, Hironao, et al.
Publicado: (2021)

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023)

Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment
por: Okubo, Hironao, et al.
Publicado: (2022)

Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular Carcinoma
por: Okubo, Hironao, et al.
Publicado: (2022)

L-carnitine prevents lenvatinib-induced muscle toxicity without impairment of the anti-angiogenic efficacy
por: Jing, Zheng, et al.
Publicado: (2023)

Gadoxetic acid–enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C
por: Okubo, Hironao, et al.
Publicado: (2018)

Endobronchial Watanabe Spigot Placement for Hepatic Abscess and Bronchobiliary Fistula Following Radiofrequency Ablation for Hepatocellular Carcinoma
por: Nishioki, Toshihiko, et al.
Publicado: (2022)

Retrograde double-balloon endoscopy-assisted electrohydraulic lithotripsy: Effective treatment of a true-enterolith associated with Crohn’s disease
por: Haga, Keiichi, et al.
Publicado: (2023)

Benefit of an action camera in endoscopy education for medical students under COVID-19
por: Uchiyama, Akira, et al.
Publicado: (2023)

Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient
por: Fukuo, Yuka, et al.
Publicado: (2021)

A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Connection between HPS and ACLF: a solution of chaos?
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

Dust flow analysis by low coherence Doppler lidar
por: Okubo, Kosuke, et al.
Publicado: (2023)

Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy
por: Colombo, Carla, et al.
Publicado: (2018)

Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration
por: Takeda, Tsutomu, et al.
Publicado: (2017)

Rapid disease progression after discontinuation of lenvatinib in thyroid cancer
por: Yamazaki, Haruhiko, et al.
Publicado: (2020)

Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis
por: Sato, Shinya, et al.
Publicado: (2020)

Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report
por: Aoki, Yoichi, et al.
Publicado: (2023)

AI-Based Radiological Imaging for HCC: Current Status and Future of Ultrasound
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
por: Shiina, Shuichiro, et al.
Publicado: (2023)

Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
por: Sato, Shinya, et al.
Publicado: (2019)

Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy
por: Ishii, Shigeto, et al.
Publicado: (2020)

The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis
por: Muraishi, Nozomu, et al.
Publicado: (2023)

Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
por: Masaki, Chie, et al.
Publicado: (2021)

L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis
por: Ohara, Masatsugu, et al.
Publicado: (2018)

The Effects of Oral L-Carnitine Supplementation on Physical Capacity and Lipid Metabolism in Chronic Hemodialysis Patients
por: Kudoh, Yasuo, et al.
Publicado: (2014)

Lenvatinib for poorly differentiated carcinoma of the anterior mediastinum
por: Yanagihara, Toyoshi, et al.
Publicado: (2021)

Ablation for Benign Liver Tumors: Current Concepts and Limitations
por: Maruyama, Hitoshi, et al.
Publicado: (2023)

Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Carnitine and Depression
por: Liu, Ting, et al.
Publicado: (2022)

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Hiccups as the first presentation of secondary adrenal insufficiency associated with advanced cervical cancer
por: Sawamura, Toshitaka, et al.
Publicado: (2022)

Assessment of carnitine excretion and its ratio to plasma free carnitine as a biomarker for primary carnitine deficiency in newborns
por: Crefcoeur, Loek L., et al.
Publicado: (2022)

Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
por: Endo, Kei, et al.
Publicado: (2020)

Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI
por: Kuwano, Akifumi, et al.
Publicado: (2022)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

Efficacy of Nanofiber Sheets Incorporating Lenvatinib in a Hepatocellular Carcinoma Xenograft Model
por: Yoshida, Terufumi, et al.
Publicado: (2022)

Metabolic flexibility and carnitine flux: The role of carnitine acyltransferase in glucose homeostasis
por: Miyata, Yugo, et al.
Publicado: (2013)

Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis
por: Shimizu, Satoshi, et al.
Publicado: (2019)

Cross-species comparison in nonclinical pharmacokinetics of lenvatinib by a simple HPLC with ultraviolet detection
por: Mizuo, Hitoshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vqfmq9p51jpbvc1ejt033qep9v